Loading clinical trials...
Loading clinical trials...
A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability and Efficacy of Tirasemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
Conditions
Interventions
Tirasemtiv
Placebo tablets
Locations
81
United States
St. Joseph's Hospital & Medical Center - Barrow Neurology Clinics
Phoenix, Arizona, United States
University of California San Diego
La Jolla, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of California, Irvine
Orange, California, United States
University of California Davis Medical Center
Sacramento, California, United States
Forbes Norris MDA/ALS Research Center
San Francisco, California, United States
Start Date
September 3, 2015
Primary Completion Date
March 9, 2017
Completion Date
September 27, 2017
Last Updated
September 9, 2020
NCT05204017
NCT07322003
NCT07414212
NCT07401121
NCT05104710
NCT03233646
Lead Sponsor
Cytokinetics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions